Fondazione Policlinico Universitario A. Gemelli, IRCCS, UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Rome, Italy
Division of Obstetrics and Gynaecology, Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden.
Int J Gynecol Cancer. 2020 Apr;30(4):441-447. doi: 10.1136/ijgc-2020-001226. Epub 2020 Mar 5.
This is a report from the 21st Meeting of the European Society of Gynaecological Oncology (ESGO 2019) held in Athens, Greece, November 2-5, 2019. The conference offered state of the art educational sessions, and oral and poster abstract presentations. The general sessions throughout the meeting focused not only on prevention, screening, diagnosis, treatment, and translational research but also on emerging trends. Current innovations in gynecological cancers were also discussed. The new rare tumor guidelines project, a joint initiative with the ESGO-Gynecologic Cancer InterGroup, was officially presented for the first time. Moreover, other developments achieved with other societies, such as the European Society for Medical Oncology for ovarian cancer, the European Federation for Colposcopy for cervical cancer prevention and screening, and the European Society for Pediatric Oncology for gynecologic cancers in adolescents, were presented. Here we highlight the key results of the latest gynecological cancer trials that were presented for the first time at ESGO 2019 and added great value to this prestigious scientific congress.
这是第 21 届欧洲妇科肿瘤学会（ESGO 2019）会议的报告，会议于 2019 年 11 月 2 日至 5 日在希腊雅典举行。本次会议提供了最先进的教育课程，以及口头和海报摘要演讲。整个会议的全体会议不仅关注预防、筛查、诊断、治疗和转化研究，还关注新兴趋势。还讨论了妇科癌症的最新创新。该项目是与 ESGO-妇科癌症 InterGroup 的联合倡议，首次正式提出。此外，还介绍了与其他学会取得的其他进展，例如欧洲肿瘤内科学会（ESMO）的卵巢癌、欧洲阴道镜检查学会（ESGO）的宫颈癌预防和筛查、以及欧洲儿科肿瘤学会（SIOP）的青少年妇科癌症。在这里，我们重点介绍了首次在 ESGO 2019 年会议上提出的最新妇科癌症试验的关键结果，这些结果为这一享有盛誉的科学大会增添了巨大价值。
